相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis
Rokeya Tasneen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Role of the Cys154Arg Substitution in Ribosomal Protein L3 in Oxazolidinone Resistance in Mycobacterium tuberculosis
Gaelle Guiewi Makafe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014)
Robert K. Flamm et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones
Dario Cattaneo et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
Robert S. Wallis et al.
LANCET INFECTIOUS DISEASES (2016)
Prolonged inductive effect of rifampicin on linezolid exposure
Cristina Gervasoni et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Linezolid for multidrug-resistant tuberculosis in HIV-infected and -uninfected patients
Jennifer Hughes et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study
Mathieu S. Bolhuis et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Access to new medications for the treatment of drug-resistant tuberculosis: Patient, provider and community perspectives
Erica Lessem et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis
N. Ndjeka et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
Clinical Outcomes of Linezolid Treatment for Extensively Drug-Resistant Tuberculosis in Beijing, China: A Hospital-Based Retrospective Study
Yu Liu et al.
JAPANESE JOURNAL OF INFECTIOUS DISEASES (2015)
Linezolid for XDR-TB - Final Study Outcomes
Myungsun Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy
Ashley N. Brown et al.
MBIO (2015)
Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis
Taeksun Song et al.
EBIOMEDICINE (2015)
Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China
Shenjie Tang et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Low minimal inhibitory concentrations of linezolid against rnultidrug-resistant tuberculosis strains
Timo Weiss et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Bactericidal Activity and Mechanism of Action of AZD5847, a Novel Oxazolidinone for Treatment of Tuberculosis
V. Balasubramanian et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Linezolid-Induced Lactic Acidosis in Two Liver Transplant Patients with the Mitochondrial DNA A2706G Polymorphism
J. L. Del Pozo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
In Vitro and In Vivo Activities of Three Oxazolidinones against Nonreplicating Mycobacterium tuberculosis
Ming Zhang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
Abdullah Alsultan et al.
DRUGS (2014)
Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients
H. -Y. Dong et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Linezolid in the treatment of extensively drug-resistant tuberculosis
L. Zhang et al.
INFECTION (2014)
Activity of linezolid-containing regimens against multidrug-resistant tuberculosis in mice
Weijie Zhao et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients
Kazuaki Matsumoto et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China
Zhijian Zhang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study
Elize Pietersen et al.
LANCET (2014)
Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis
Robert S. Wallis et al.
PLOS ONE (2014)
Clinical Validation of the Analysis of Linezolid and Clarithromycin in Oral Fluid of Patients with Multidrug-Resistant Tuberculosis
M. S. Bolhuis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Can Intermittent Dosing Optimize Prolonged Linezolid Treatment of Difficult Multidrug-Resistant Tuberculosis?
Kwok-Chiu Chang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients
Mathieu S. Bolhuis et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Drug concentration in Lung tissue in multidrug-resistant tuberculosis
Onno W. Akkerman et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
In vitro effect of three-drug combinations of antituberculous agents against multidrug-resistant Mycobacterium tuberculosis isolates
Emma Rey-Jurado et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
In vitro activities of PNU-100480 and linezolid against drug-susceptible and drug-resistant Mycobacterium tuberculosis isolates
Peter C. W. Yip et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Activity and interactions of levofloxacin, linezolid, ethambutol and amikacin in three-drug combinations against Mycobacterium tuberculosis isolates in a human macrophage model
Emma Rey-Jurado et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia
Yoko Nukui et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Population Pharmacokinetic Analysis of Linezolid in Low Body Weight Patients With Renal Dysfunction
Yasuhiro Tsuji et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Programmatically Selected Multidrug-Resistant Strains Drive the Emergence of Extensively Drug-Resistant Tuberculosis in South Africa
Borna Mueller et al.
PLOS ONE (2013)
Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome
Katherine S. Long et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Adverse Effects of Antimicrobials via Predictable or Idiosyncratic Inhibition of Host Mitochondrial Components
Alison E. Barnhill et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Linezolid in Patients with Multidrug-Resistant Tuberculosis
D. H. Vu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
rplC T460C Identified as a Dominant Mutation in Linezolid-Resistant Mycobacterium tuberculosis Strains
Patrick Beckert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy
Jotam G. Pasipanodya et al.
CLINICAL INFECTIOUS DISEASES (2012)
Dried Blood Spots: A New Tool for Tuberculosis Treatment Optimization
D. H. Vu et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis
Giovanni Sotgiu et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients
Won-Jung Koh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients
Federico Pea et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
Myungsun Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis
Christopher Fitzpatrick et al.
PHARMACOECONOMICS (2012)
An Oracle: Antituberculosis Pharmacokinetics-Pharmacodynamics, Clinical Correlation, and Clinical Trial Simulations To Predict the Future
Jotam Pasipanodya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis
Robert S. Wallis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Susceptibility of Clinical Mycobacterium tuberculosis Isolates to a Potentially Less Toxic Derivate of Linezolid, PNU-100480
J. W. C. Alffenaar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Interaction between linezolid and Mycobacterium tuberculosis in an experimental in vitro model
Rosa Cremades et al.
APMIS (2011)
Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective
Johan W. Mouton et al.
DRUG RESISTANCE UPDATES (2011)
Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis
T. Schon et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2011)
Unexpected Effect of Rifampin on the Pharmacokinetics of Linezolid: In Silico and In Vitro Approaches to Explain Its Mechanism
Kuan Gandelman et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability
Shashikant Srivastava et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Clarithromycin Significantly Increases Linezolid Serum Concentrations
Mathieu S. Bolhuis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis
Federico Pea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients
Jan-Willem C. Alffenaar et al.
CLINICAL PHARMACOKINETICS (2010)
Pharmacological Issues of Linezolid An Updated Critical Review
Antonello Di Paolo et al.
CLINICAL PHARMACOKINETICS (2010)
Mitochondrial pharmacogenomics: barcode for antibiotic therapy
David Pacheu-Grau et al.
DRUG DISCOVERY TODAY (2010)
Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction
Kazuaki Matsumoto et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Linezolid Penetration Into Cerebrospinal Fluid and Brain Tissue
A. Tsona et al.
JOURNAL OF CHEMOTHERAPY (2010)
Pharmacokinetics and Whole-Blood Bactericidal Activity against Mycobacterium tuberculosis of Single Doses of PNU-100480 in Healthy Volunteers
Robert S. Wallis et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Biomarkers for tuberculosis disease activity, cure, and relapse
Robert S. Wallis et al.
LANCET INFECTIOUS DISEASES (2010)
Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains
Ida Parwati et al.
LANCET INFECTIOUS DISEASES (2010)
Limited Sampling Strategies for Therapeutic Drug Monitoring of Linezolid in Patients With Multidrug-Resistant Tuberculosis
Jan-Willem C. Alffenaar et al.
THERAPEUTIC DRUG MONITORING (2010)
Addition of PNU-100480 to First-Line Drugs Shortens the time Needed to Cure Murine Tuberculosis
Kathy N. Williams et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model
K. N. Williams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Differences in Cell Wall Thickness between Resistant and Nonresistant Strains of Mycobacterium tuberculosis: Using Transmission Electron Microscopy
Ali Akbar Velayati et al.
CHEMOTHERAPY (2009)
Fatal lactic acidosis after prolonged linezolid exposure for treatment of multidrug-resistant tuberculosis
David Boutoille et al.
European Journal of Internal Medicine (2009)
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis
G. B. Migliori et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Population Pharmacokinetic Analysis of Linezolid in Patients With Infectious Disease: Application to Lower Body Weight and Elderly Patients
Sadahiro Abe et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Early and Extended Early Bactericidal Activity of Linezolid in Pulmonary Tuberculosis
Reynaldo Dietze et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years
Tsi-Shu Huang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Use of an in vitro pharmacodynamic model to derive a linezolid regimen that optimizes bacterial kill and prevents emergence of resistance in Bacillus anthracis
A. Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey
Susan E. Beekmann et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2008)
Clinical pharmacology of linezolid: an oxazolidinone antimicrobial agent
Tina Q Tan et al.
Expert Review of Clinical Pharmacology (2008)
In vitro-selected linezolid-resistant Mycobacterium tuberculosis mutants
Doris Hillemann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome
Masashi Narita et al.
PHARMACOTHERAPY (2007)
The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria
Karen L. Leach et al.
MOLECULAR CELL (2007)
First linezolid-resistant clinical isolates of Mycobacterium tuberculosis
Elvira Richter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Pharmacokinetic/pharmaeodynamic factors influencing emergence of resistance to linezolid in an in vitro model
Lauren M. Boak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid and rifampin
Benjamin C. Gebhart et al.
PHARMACOTHERAPY (2007)
Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia
Gloria Garrabou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to Fluoroquinolones and linezolid
I. Escribano et al.
CHEMOTHERAPY (2007)
High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency
Yen-Hung Lin et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Linezolid and serotonergic drug interactions: A retrospective survey
Jeremy J. Taylor et al.
CLINICAL INFECTIOUS DISEASES (2006)
A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa
T. M. Han et al.
KIDNEY INTERNATIONAL (2006)
Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones
EE McKee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Serotonin toxicity associated with the use of linezolid: A review of postmarketing data
KR Lawrence et al.
CLINICAL INFECTIOUS DISEASES (2006)
Linezolid-induced inhibition of mitochondrial protein synthesis
AS De Vriese et al.
CLINICAL INFECTIOUS DISEASES (2006)
Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients
H McIlleron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Mitochondrial toxicity associated with linezolid
A Soriano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Oxazolidinones inhibit cellular proliferation via inhibition of mitochondrial protein synthesis
EE Nagiec et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses
P Dehghanyar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Mutant prevention concentration:: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis
JC Rodríguez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Oxazolidinones: activity, mode of action, and mechanism of resistance
B Bozdogan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Linezolid in the treatment of osteomyelitis: Results of compassionate use experience
CR Rayner et al.
INFECTION (2004)
Peripheral neuropathy associated with prolonged use of linezolid
AM Bressler et al.
LANCET INFECTIOUS DISEASES (2004)
Antimicrobial resistance to linezolid
VG Meka et al.
CLINICAL INFECTIOUS DISEASES (2004)
Intrapulmonary penetration of linezolid
D Honeybourne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Mitochondrial threshold effects
R Rossignol et al.
BIOCHEMICAL JOURNAL (2003)
Population pharmacokinetics of linezolid in patients treated in a compassionate-use program
AK Meagher et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Whole blood bactericidal activity during treatment of pulmonary tuberculosis
RS Wallis et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs
L Alcala et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Ribosomal and non-ribosomal resistance to oxazolidinones: species-specific idiosyncrasy of ribosomal alterations
P Sander et al.
MOLECULAR MICROBIOLOGY (2002)
In vivo pharmacodynamics of a new oxazolidinone (linezolid)
D Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Intrapulmonary pharmacokinetics of linezolid
JE Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
H-1 nuclear magnetic resonance study of oxazolidinone binding to bacterial ribosomes
CC Zhou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Pharmacokinetics and tissue penetration of linezolid following multiple oral doses
T Gee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action
LQ Xiong et al.
JOURNAL OF BACTERIOLOGY (2000)
Activity of linezolid against Gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors
M Fines et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore
E Jacotot et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
